KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Free Cash Flow (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Free Cash Flow for 16 consecutive years, with $3.3 billion as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Free Cash Flow fell 0.84% year-over-year to $3.3 billion, compared with a TTM value of $8.7 billion through Dec 2024, up 25.12%, and an annual FY2025 reading of $7.8 billion, up 7.58% over the prior year.
  • Free Cash Flow was $3.3 billion for Q4 2024 at Thermo Fisher Scientific, up from $2.2 billion in the prior quarter.
  • Across five years, Free Cash Flow topped out at $3.3 billion in Q4 2023 and bottomed at $103.0 million in Q1 2020.
  • Average Free Cash Flow over 5 years is $1.8 billion, with a median of $1.7 billion recorded in 2021.
  • The sharpest move saw Free Cash Flow skyrocketed 1210.68% in 2021, then tumbled 82.65% in 2023.
  • Year by year, Free Cash Flow stood at $2.8 billion in 2020, then crashed by 40.94% to $1.6 billion in 2021, then skyrocketed by 80.63% to $2.9 billion in 2022, then increased by 12.97% to $3.3 billion in 2023, then decreased by 0.84% to $3.3 billion in 2024.
  • Business Quant data shows Free Cash Flow for TMO at $3.3 billion in Q4 2024, $2.2 billion in Q3 2024, and $2.0 billion in Q2 2024.